Biodesix names James Jett new chief medical officer

Biodesix names James Jett new chief medical officer

BOULDER -- Biodesix, Inc . announced the appointment of internationally recognized lung cancer expert James Jett , M.D., as chief medical officer. Dr. Jett joins Steven Springmeyer , M.D.... Read More

Wednesday October 16, 2019 0 comments Tags: Boulder, Biodesix, James Jett, Steven Springmeyer, Scott Hutton

Biodesix issued new patent for improved blood specimen collection device

Biodesix issued new patent for improved blood specimen collection device

BOULDER -- Biodesix, Inc . announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease-of-use in blood... Read More

Friday October 4, 2019 0 comments Tags: Boulder, Biodesix, Biodesix Collection Device, Gary Pestano, Scott Hutton

Biodesix appoints Robert Georgantas senior VP

Biodesix appoints Robert Georgantas senior VP

BOULDER -- Biodesix, Inc . announced the appointment of Robert W. Georgantas III, Ph.D., as the companys senior vice president of research and translational science. Georgantas research... Read More

Wednesday August 14, 2019 0 comments Tags: Boulder, Biodesix, Robert Georgantas, Scott Hutton, Heinrich Roder

Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

BOULDER -- Biodesix Inc. and London-based Immodulon Therapeutics Limited, announced they have entered into a biomarker research collaboration. The partnership will focus on the analysis of... Read More

Tuesday July 30, 2019 0 comments Tags: Boulder, Biodesix, Immodulon, David Brunel

Biodesix partners with Thermo Fisher Scientific on blood-based cancer test

Biodesix partners with Thermo Fisher Scientific on blood-based cancer test

BOULDER -- Biodesix, Inc , a leader in blood-based lung cancer diagnostic solutions, announced it has entered into an agreement with Thermo Fisher Scientific designed to bring a blood-based... Read More

Wednesday July 10, 2019 0 comments Tags: Boulder, Biodesix, Thermo Fisher Scientific, David Brunel

Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics

Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics

BOULDER-- Biodesix and Canada-based MRM Proteomics Inc. announced they will partner to create novel assays to answer critical clinical questions within the lung cancer continuum of care. ... Read More

Tuesday January 29, 2019 0 comments Tags: Boulder, Biodesix, MRM Proteomics, Scott Hutton, lung cancer

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

By Steve Porter LOVELAND Theres a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. Its called precision... Read More

By: steveporter Monday August 1, 2016 0 comments Tags: Loveland, NoCoBio Cluster, Innosphere, Deanna Scott, Chris Tompkins, Biodesix, Paul Beresford, KromaTid, Steven Schuster, UCHealth North, Alan Rudolph, Unsu Jung, MCR, Dana Stangel, Dr. Gary Luckasen

Biodesix: New clinical findings show diagnostic advances for novel drug

Biodesix: New clinical findings show diagnostic advances for novel drug

BOULDER -- Biodesix Inc . announced new clinical findings that show its novel investigational test, BDX008 based on profiling serum proteins identifies patients with advanced melanoma who are... Read More

Tuesday November 10, 2015 0 comments Tags: Boulder, Biodesix, Richard Hockett, melanoma, nivolumab